MoneyWorks4Me

Shilpa Medicare - Quaterly Results

23 May 2024 Evaluate
The sales moved up 31.52% to Rs. 874.52 millions for the March 2024 quarter as compared to Rs. 664.95 millions during the year-ago period.The Total Profit for the quarter ended March 2024 of Rs. 97.37 millions grew from Rs.-289.25 millionsOperating profit for the quarter ended March 2024 rose to 302.07 millions as compared to 65.60 millions of corresponding quarter ended March 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 874.52 664.95 31.52 3097.87 2477.02 25.06 3097.87 2477.02 25.06
Other Income 232.47 203.32 14.34 891.16 686.44 29.82 891.16 686.44 29.82
PBIDT 302.07 65.60 360.47 1154.08 246.42 368.34 1154.08 246.42 368.34
Interest 27.11 66.08 -58.97 172.57 208.25 -17.13 172.57 208.25 -17.13
PBDT 237.12 -150.09 -257.99 877.00 -117.30 -847.66 877.00 -117.30 -847.66
Depreciation 122.87 119.79 2.57 496.11 465.48 6.58 496.11 465.48 6.58
PBT 114.25 -269.88 -142.33 380.89 -582.78 -165.36 380.89 -582.78 -165.36
TAX 16.88 19.37 -12.85 111.52 -87.93 -226.83 111.52 -87.93 -226.83
Deferred Tax -4.97 29.97 -116.58 -1.35 -4.27 -68.38 -1.35 -4.27 -68.38
PAT 97.37 -289.25 -133.66 269.37 -494.85 -154.43 269.37 -494.85 -154.43
Equity 86.80 86.80 0.00 86.80 86.80 0.00 86.80 86.80 0.00
PBIDTM(%) 34.54 9.87 250.12 37.25 9.95 274.48 37.25 9.95 274.48
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..